Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

488 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The secret ally: immunostimulation by anticancer drugs.
Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: zitvogel l. Nat Rev Drug Discov. 2012 Feb 3;11(3):215-33. doi: 10.1038/nrd3626. Nat Rev Drug Discov. 2012. PMID: 22301798 Review.
Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects.
Fernandez N, Duffour MT, Perricaudet M, Lotze MT, Tursz T, Zitvogel L. Fernandez N, et al. Among authors: zitvogel l. Cytokines Cell Mol Ther. 1998 Mar;4(1):53-65. Cytokines Cell Mol Ther. 1998. PMID: 9557217 Review.
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.
Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Zitvogel L, et al. Nat Med. 1998 May;4(5):594-600. doi: 10.1038/nm0598-594. Nat Med. 1998. PMID: 9585234
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.
Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. Fernandez NC, et al. Among authors: zitvogel l. Nat Med. 1999 Apr;5(4):405-11. doi: 10.1038/7403. Nat Med. 1999. PMID: 10202929
Dendritic cells or their exosomes are effective biotherapies of cancer.
Zitvogel L, Fernandez N, Lozier A, Wolfers J, Regnault A, Raposo G, Amigorena S. Zitvogel L, et al. Eur J Cancer. 1999 Aug;35 Suppl 3:S36-8. doi: 10.1016/s0959-8049(99)00090-8. Eur J Cancer. 1999. PMID: 10645221 Review. No abstract available.
[Antitumor cellular immunotherapy: the breakthrough of dendritic cells].
Angevin E, André F, Zitvogel L. Angevin E, et al. Among authors: zitvogel l. Bull Cancer. 2000 Jan;87(1):107-15. Bull Cancer. 2000. PMID: 10673639 Review. French. No abstract available.
Dendritic cell-based immunotherapy of cancer.
Zitvogel L, Angevin E, Tursz T. Zitvogel L, et al. Ann Oncol. 2000;11 Suppl 3:199-205. doi: 10.1093/annonc/11.suppl_3.199. Ann Oncol. 2000. PMID: 11079142 Review. No abstract available.
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.
Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L. Wolfers J, et al. Among authors: zitvogel l. Nat Med. 2001 Mar;7(3):297-303. doi: 10.1038/85438. Nat Med. 2001. PMID: 11231627
Exosomes in cancer immunotherapy: preclinical data.
Andre F, Andersen M, Wolfers J, Lozier A, Raposo G, Serra V, Ruegg C, Flament C, Angevin E, Amigorena S, Zitvogel L. Andre F, et al. Among authors: zitvogel l. Adv Exp Med Biol. 2001;495:349-54. doi: 10.1007/978-1-4615-0685-0_49. Adv Exp Med Biol. 2001. PMID: 11774591 Review. No abstract available.
From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.
Schartz NE, Chaput N, André F, Zitvogel L. Schartz NE, et al. Among authors: zitvogel l. Curr Opin Mol Ther. 2002 Aug;4(4):372-81. Curr Opin Mol Ther. 2002. PMID: 12222875 Review.
488 results
Jump to page